Assessment of the immune system in 55 Iranian patients with vitiligo

被引:15
作者
Farrokhi, S
Hojjat-Farsangi, M
Noohpisheh, MK
Tahmasbi, R
Rezaei, N
机构
[1] Boushehr Univ Med Sci, Dept Immunol, Boushehr, Iran
[2] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran
关键词
antinuclear antibody; autoimmune; melanocyte; pathogenesis; vitiligo;
D O I
10.1111/j.1468-3083.2005.01295.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Vitiligo is an acquired idiopathic hypomelanotic disorder characterized by circumscribed depigmented macules resulting from the loss of cutaneous melanocytes. Objective In order to evaluate the immune system of Iranian patients with vitiligo, this study was accomplished. Methods Fifty-five Iranian patients with vitiligo and 60 healthy persons as control were investigated in this study. The laboratory techniques were included: antimelanocyte antibody (AMA) and antinuclear antibody (ANA) with indirect immunoflorescent test, C3 and C4 levels with single radial immunodiffusion (SRID), and rheumatoid factor (RF) with enzyme-linked immunosorbent assay (ELISA). Results AMA was positive in 17 patients (30.9%) and was negative in the entire control group (P < 0.0001). ANA was positive in 4 patients (7.3%), which was insignificantly higher than control group (1.7%). IgM-RF was positive in 6 patients (10.8%) while it was negative in the entire control group (P = 0.027). C3 and C4 values decreased in 14 patients (25.5%), which was significantly higher than control group (P < 0.001). Conclusion The important role of the immune system in the pathogenesis of vitiligo could be suggested. In addition, the autoimmune hypothesis of vitiligo could be confirmed based on the results of this study.
引用
收藏
页码:706 / 711
页数:6
相关论文
共 29 条
[1]   FURTHER EVIDENCE FOR INVOLVEMENT OF BOTH CELL-MEDIATED AND HUMORAL IMMUNITY IN GENERALIZED VITILIGO [J].
ABDELNASER, MB ;
KRUGERKRASAGAKES, S ;
KRASAGAKIS, K ;
GOLLNICK, H ;
ORFANOS, CE .
PIGMENT CELL RESEARCH, 1994, 7 (01) :1-8
[2]   Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo [J].
Adamus, G ;
Machnicki, M ;
Elerding, H ;
Sugden, B ;
Blocker, YS ;
Fox, DA .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :523-533
[3]   Antinuclear antibodies:: to penetrate or not to penetrate, that was the question [J].
Alarcón-Segovia, D .
LUPUS, 2001, 10 (05) :315-318
[4]   ANTIBODY TO NUCLEAR RIBONUCLEOPROTEIN PENETRATES LIVE HUMAN MONONUCLEAR-CELLS THROUGH FC RECEPTORS [J].
ALARCONSEGOVIA, D ;
RUIZARGUELLES, A ;
FISHBEIN, E .
NATURE, 1978, 271 (5640) :67-69
[5]   SERUM ANTIBODIES IN VITILIGO PATIENTS [J].
BYSTRYN, JC .
CLINICS IN DERMATOLOGY, 1989, 7 (02) :136-145
[6]   A critical appraisal of vitiligo etiologic theories.: Is melanocyte loss a melanocytorrhagy? [J].
Gauthier, Y ;
Andre, MC ;
Taïeb, A .
PIGMENT CELL RESEARCH, 2003, 16 (04) :322-332
[7]   IN-VIVO DESTRUCTION OF MELANOCYTES BY THE IGG FRACTION OF SERUM FROM PATIENTS WITH VITILIGO [J].
GILHAR, A ;
ZELICKSON, B ;
ULMAN, Y ;
ETZIONI, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (05) :683-686
[8]   RELATION BETWEEN THE INCIDENCE AND LEVEL OF PIGMENT CELL ANTIBODIES AND DISEASE-ACTIVITY IN VITILIGO [J].
HARNING, R ;
CUI, J ;
BYSTRYN, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (06) :1078-1080
[9]  
Kemp EH, 1998, BRIT J DERMATOL, V139, P798
[10]   Detection of tyrosinase autoantibodies in patients with vitiligo using S-35-labeled recombinant human tyrosinase in a radioimmunoassay [J].
Kemp, EH ;
Gawkrodger, DJ ;
MacNeil, S ;
Watson, PF ;
Weetman, AP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (01) :69-73